Recent study shows retrotransposons in the human genome to be responsible for age-related diseases and other health challenges. The HIV drug Lamivudine showed potential in mice trials treating age-related neurological diseases caused by inflammation. After two weeks of treatment, the cells of old mice showed reduced signs of chronic inflammation.
It is common knowledge that aging is a part of life, but a recent study aims to further unravel the mechanisms behind it.
The study, published Feb. 6 in the journal Nature, indicates that remnants of ancient viruses with DNA in the human genome may be actively pushing humans toward the wrinkles and difficulties that manifest with old age.
Promising results from a joint study between researchers at Brown and numerous other universities suggest an HIV drug, Lamivudine, could hinder these inherited molecules. This research has applications in potentially treating age-associated neurological diseases and other disorders, according to the study’s authors. Read More